# Johnson & Johnson (JNJ) — Q1-2016 Earnings Results

**Report date:** 2016-04-19 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2016

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.72 | N/A | +4.94% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on innovation and meeting consumer needs.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

This earnings report indicates that Johnson & Johnson performed better than expected in terms of earnings per share. However, without revenue data and no guidance provided, investors may be cautious about the stock's future performance. The lack of a stock reaction also suggests uncertainty in the market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2016_